PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Statistics

Total Valuation

PDSB has a market cap or net worth of $47.50 million. The enterprise value is $32.00 million.

Market Cap	47.50M
Enterprise Value	32.00M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

PDSB has 47.03 million shares outstanding. The number of shares has increased by 19.89% in one year.

Current Share Class	47.03M
Shares Outstanding	47.03M
Shares Change (YoY)	+19.89%
Shares Change (QoQ)	+13.28%
Owned by Insiders (%)	3.00%
Owned by Institutions (%)	16.35%
Float	45.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.73
P/TBV Ratio	2.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.92, with a Debt / Equity ratio of 1.16.

Current Ratio	2.92
Quick Ratio	2.76
Debt / Equity	1.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.36

Financial Efficiency

Return on equity (ROE) is -156.16% and return on invested capital (ROIC) is -47.70%.

Return on Equity (ROE)	-156.16%
Return on Assets (ROA)	-42.42%
Return on Invested Capital (ROIC)	-47.70%
Return on Capital Employed (ROCE)	-118.39%
Revenue Per Employee	n/a
Profits Per Employee	-$1.53M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.39% in the last 52 weeks. The beta is 1.10, so PDSB's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	-69.39%
50-Day Moving Average	1.08
200-Day Moving Average	1.27
Relative Strength Index (RSI)	52.57
Average Volume (20 Days)	792,103

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.27M
Pretax Income	-37.77M
Net Income	-36.60M
EBITDA	-34.21M
EBIT	-34.27M
Earnings Per Share (EPS)	-$0.91

Balance Sheet

The company has $31.87 million in cash and $18.54 million in debt, giving a net cash position of $13.34 million or $0.28 per share.

Cash & Cash Equivalents	31.87M
Total Debt	18.54M
Net Cash	13.34M
Net Cash Per Share	$0.28
Equity (Book Value)	15.96M
Book Value Per Share	0.34
Working Capital	22.12M

Cash Flow

In the last 12 months, operating cash flow was -$34.37 million and capital expenditures -$1, giving a free cash flow of -$34.37 million.

Operating Cash Flow	-34.37M
Capital Expenditures	-1
Free Cash Flow	-34.37M
FCF Per Share	-$0.73

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.89%
Shareholder Yield	-19.89%
Earnings Yield	-80.73%
FCF Yield	-75.80%

Analyst Forecast

The average price target for PDSB is $10.00, which is 890.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	890.10%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 1:20.

Last Split Date	Mar 18, 2019
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2